These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30986800)

  • 1. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
    de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
    Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
    Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
    Zhang X; Shen D; Wang Y
    Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DICER1 hot-spot mutations in ovarian gynandroblastoma.
    Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
    Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
    Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
    Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
    Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.
    Nelson AT; Harris AK; Watson D; Kamihara J; Chen KS; Stall JN; Devins KM; Young RH; Olson DR; Mallinger PHR; Mitchell SG; Hoffman LM; Halliday G; Suleymanova AM; Glade Bender JL; Messinger YH; Herzog CE; Field AL; Frazier AL; Stewart DR; Dehner LP; Hill DA; Billmire DF; Schneider DT; Schultz KAP
    Gynecol Oncol; 2024 Jul; 186():117-125. PubMed ID: 38657450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
    Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
    Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
    Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
    Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
    Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 20. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
    Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
    Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.